• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Asthma – Executive Market Summary 2011 Product Image

Asthma – Executive Market Summary 2011

  • ID: 463742
  • May 2012
  • Region: Global
  • 18 Pages
  • Timely Data Resources, Inc

Executive Market Summaries were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format.  These reports are prepared by the senior market research team of Timely Data Resources.  Each Executive Market Summary provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. 

Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.  The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment.  This information is supplemented by reviews of analyst reports, company reports, and medical websites.  Sources and references are provided.  

The Asthma Executive Market Summary 2011 provides an overview of the disease and related conditions, with incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the asthma market, as well as sales of leading drugs and therapies are provided.

Note: Product cover images may vary from those shown

I. OVERVIEW
General description of the condition
Symptoms and classification by severity

II. INCIDENCE AND PREVALENCE

Incidence Table (US, England, Italy)

Prevalence Table (Canada, US, England, France, Germany, Greece, Italy, Poland, Romania, Spain, Sweden, UK, China, India, Japan, Turkey, Australia, European Union, Worldwide)
Distribution of cases by symptom severity

III. DIAGNOSIS AND TREATMENT
Goals and components of treatment
Long-term medications
Quick-relief medications
Approach to treatment of asthma exacerbations
Treatment rates

IV. DOSING AND TREATMENT COSTS
Dosing for long-term control medications
Dosing for quick-relief medications
Costs for commonly prescribed drugs

V. MARKET SIZE
Overall market size
Sales information for key pharmaceuticals

VI. COMMENTS

VII. REFERENCES/RESOURCES

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos